Fateh-Moghadam A, Mantel W, Neumeier D, Hannig Ch, Kristin H, Otte M
Klin Wochenschr. 1978 Mar 15;56(6):267-70. doi: 10.1007/BF01489171.
The concentration of beta2-microglobulin (beta2m) and carcinoembryonic antigen (CEA) was measured radioimmunologically in the sera of 79 patients with malignant disorders and 15 patients with chronic pancreatitis. Elevated levels of beta2m and CEA were found in 11 out of 22 patients with carcinoma of the pancreas, which sets off this malignancy from chronic pancreatitis and other malignant tumors. Only 3 patients with carcinoma of the pancreas exhibited serum levels within the normal range for both parameters and none of the patients with chronic pancreatitis was shown to have elevated levels of beta2m. The simultaneous determination of beta2m and CEA suggests itself for the diagnosis of pancreatic malignancy especially in the case of a tentative diagnosis of a pancreatic tumor.
采用放射免疫法检测了79例恶性疾病患者和15例慢性胰腺炎患者血清中β2-微球蛋白(β2m)和癌胚抗原(CEA)的浓度。在22例胰腺癌患者中,有11例β2m和CEA水平升高,这使得胰腺癌与慢性胰腺炎及其他恶性肿瘤区分开来。仅3例胰腺癌患者的这两项指标血清水平在正常范围内,且慢性胰腺炎患者均未显示β2m水平升高。同时检测β2m和CEA有助于胰腺癌的诊断,尤其是在初步诊断为胰腺肿瘤的情况下。